These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
731 related articles for article (PubMed ID: 24277854)
1. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Liu J; Pan S; Hsieh MH; Ng N; Sun F; Wang T; Kasibhatla S; Schuller AG; Li AG; Cheng D; Li J; Tompkins C; Pferdekamper A; Steffy A; Cheng J; Kowal C; Phung V; Guo G; Wang Y; Graham MP; Flynn S; Brenner JC; Li C; Villarroel MC; Schultz PG; Wu X; McNamara P; Sellers WR; Petruzzelli L; Boral AL; Seidel HM; McLaughlin ME; Che J; Carey TE; Vanasse G; Harris JL Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20224-9. PubMed ID: 24277854 [TBL] [Abstract][Full Text] [Related]
2. Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma. Li J; Wu G; Xu Y; Li J; Ruan N; Chen Y; Zhang Q; Xia Q Biomed Res Int; 2020; 2020():2527643. PubMed ID: 32104684 [TBL] [Abstract][Full Text] [Related]
3. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway. Shah K; Panchal S; Patel B Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106 [TBL] [Abstract][Full Text] [Related]
4. Porcupine inhibitor LGK‑974 inhibits Wnt/β‑catenin signaling and modifies tumor‑associated macrophages resulting in inhibition of the malignant behaviors of non‑small cell lung cancer cells. Tang Y; Jiang M; Chen A; Qu W; Han X; Zuo J; Xu G; Song Y; Chen C; Ke X Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080032 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms and inhibition of Porcupine-mediated Wnt acylation. Liu Y; Qi X; Donnelly L; Elghobashi-Meinhardt N; Long T; Zhou RW; Sun Y; Wang B; Li X Nature; 2022 Jul; 607(7920):816-822. PubMed ID: 35831507 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer. Proffitt KD; Madan B; Ke Z; Pendharkar V; Ding L; Lee MA; Hannoush RN; Virshup DM Cancer Res; 2013 Jan; 73(2):502-7. PubMed ID: 23188502 [TBL] [Abstract][Full Text] [Related]
7. Novel PORCN inhibitor WHN-88 targets Wnt/β-catenin pathway and prevents the growth of Wnt-driven cancers. Yang Q; Qin T; An T; Wu H; Xu G; Xiang J; Lei K; Zhang S; Xia J; Su G; Wang D; Xue M; Kong L; Zhang W; Wu S; Li Y Eur J Pharmacol; 2023 Apr; 945():175628. PubMed ID: 36858339 [TBL] [Abstract][Full Text] [Related]
8. LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/β-CATENIN pathway. Yang JM; Huang HM; Cheng JJ; Huang CL; Lee YC; Chiou CT; Huang HT; Huang NK; Yang YC Toxicology; 2018 Dec; 410():65-72. PubMed ID: 30205152 [TBL] [Abstract][Full Text] [Related]
9. Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes. Guimaraes PPG; Tan M; Tammela T; Wu K; Chung A; Oberli M; Wang K; Spektor R; Riley RS; Viana CTR; Jacks T; Langer R; Mitchell MJ J Control Release; 2018 Nov; 290():75-87. PubMed ID: 30290244 [TBL] [Abstract][Full Text] [Related]
10. Chemical Modulation of WNT Signaling in Cancer. Zhang LS; Lum L Prog Mol Biol Transl Sci; 2018 Jan; 153():245-269. PubMed ID: 29389519 [TBL] [Abstract][Full Text] [Related]
12. Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors. Dong Y; Li K; Xu Z; Ma H; Zheng J; Hu Z; He S; Wu Y; Sun Z; Luo L; Li J; Zhang H; Zhang X Bioorg Med Chem; 2015 Nov; 23(21):6855-68. PubMed ID: 26455655 [TBL] [Abstract][Full Text] [Related]
13. WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma. Zimmerli D; Cecconi V; Valenta T; Hausmann G; Cantù C; Restivo G; Hafner J; Basler K; van den Broek M Oncogene; 2018 Jul; 37(27):3753-3762. PubMed ID: 29662191 [TBL] [Abstract][Full Text] [Related]
14. Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines. Schmidtova S; Kalavska K; Liskova V; Plava J; Miklikova S; Kucerova L; Matuskova M; Rojikova L; Cierna Z; Rogozea A; Konig H; Albany C; Mego M; Chovanec M Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923996 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells. Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983 [TBL] [Abstract][Full Text] [Related]
16. Delivery of the Porcupine Inhibitor WNT974 in Mice. Zhang LS; Lum L Methods Mol Biol; 2016; 1481():111-7. PubMed ID: 27590157 [TBL] [Abstract][Full Text] [Related]